siRNA TREATMENT AGENT FOR HEPATITIS C VIRUS, TARGETING HCV IRES

摘要

The present invention relates to a siRNA treatment agent for hepatitis C virus, targeting hepatitis C virus internal ribosome entry site (HCV IRES). According to the present invention, the siRNA which target HCV IRES gene and shows anti-HCV activities. The siRNA or a lipid formulation thereof can be delivered into the human body especially hepatocyte, thereby effectively used as a treatment agent for hepatitis C.;COPYRIGHT KIPO 2016